Sellbyville, DE -- (SBWIRE) -- 05/29/2019 -- The U.S. Home Infusion Therapy Market is set to exceed USD 13.5 billion by 2024; according to a new research report by Global Market Insights. Increasing rates of hospital acquired infections have impacted the market growth positively. In American hospitals, infections associated with health care account for around 1.7 million infections and 99,000 deaths every year. These infections lead to chronic diseases that require continuous monitoring; thus, accelerate demand for home infusion therapies.

Rising prevalence of chronic diseases such as diabetes and cancer will act high impacting factor for growth of U.S. home infusion therapy market. Around 13 million Americans suffer from chronic diseases, requiring special care and continuous administration of fluids to maintain health, thereby fueling demand for home infusion therapy.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2641

Occurrence of chronic diseases is frequent among geriatric population as compared to the young adults. Elderly people generally prefer home infusion therapy due to its ease in operation and convenience associated with its use. Increasing number of surgical procedures dependent on external supply of nutrition will positively influence adoption of home infusion therapy.

Technological advancements pertaining to home infusion pump has accelerated adoption rate of home infusion therapy. For instance, integration of advanced technology in infusion pumps have reduced the level of errors while administering fluids into the patient?s body. However, Improper reimbursement scenario has negatively affected the market growth by reducing the demand for home infusion therapies. Although, affordability issues have been resolved by some American medical insurance companies that will help in increasing the demand for home infusion therapy services over the forecast period.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Halyard Health
- ICU Medical
- Amsino International Inc.
- BKK B. Braun Melsungen AG
- CME (Caesarea Medical Electronics Ltd.)
- Baxter International Inc.
- Smiths Medical
- Terumo Medical Corporation
- Becton Dickinson
- Fresenius Kabi USA

Infusion pump business segment dominated the U.S. home infusion therapy market in 2017 and is expected to grow significantly over the forecast period. The growth of the segment is accounted to technological developments in the device leading to reduction in errors that otherwise occurred while using the conventional pumps.

Anti-infectives business segment accounted to largest share in 2017 owing to increasing prevalence of skin infections such as candidemia, generating significant demand for anti-infectives therapy. American associations such as National Home Infusion Association (NHIA) are focusing on implementing strategic decisions to develop the schemes for home infusion that have resolved the affordability issues of geriatric population will further propel industry growth.

South Atlantic home infusion therapy market will grow due to growing geriatric population, prone to suffering from infections due to reduced immunity. Elderly people generally suffer hospital acquired infections as well as other bacterial and viral infections that require subsequent treatments. Moreover, growing preference for home infusion therapies has increased due to ease and convenience of receiving the treatment at home will further propel industry growth.

Pacific Central home infusion therapy market growth will show considerable growth rate owing to an increase in number of home infusion therapy pharmacies. Increasing prevalence of diseases coupled with growing geriatric population has increased the demand for home infusion therapies in the region.

Some of the major industry players competing in U.S. home infusion therapy market are Amsino International, Baxter International, B.Braun Melsungen AG, Becton Dickinson, Caesarea Medical Electronics, Fresenius Kabi, Halyard Health, ICU Medical, Moog, Smiths Medical, and Terumo Corporation.

U.S. Home Infusion Therapy Market by Product

1 Infusion pump
2 Intravenous sets
3 IV cannulas
4 Needleless connectors

U.S. Home Infusion Therapy Market by Application

1 Anti-infectives
2 Hydration therapy
3 Chemotherapy
4 Enteral nutrition
5 Parenteral nutrition
6 Specialty pharmaceuticals

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2641

Chapter 1. Methodology

1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary

2.1. U.S. Home Infusion Therapy industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Regional trends

Chapter 3. U.S. Home Infusion Therapy Industry Insights

3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Growing hospital acquired infections
3.3.1.2. Rising prevalence of chronic diseases
3.3.1.3. Advancements in technology
3.3.1.4. Growing geriatric population
3.3.1.5. Presence of homecare facilities

Chapter 5. U.S. Home Infusion Therapy Market, By Application

5.1. U.S. Home Infusion Therapy market share, by application, 2017 & 2024

5.2. Anti-infectives
5.2.1. Market estimates and forecast, by region, 2013 – 2024

5.3. Hydration therapy
5.3.1. Market estimates and forecast, by region, 2013 – 2024

5.4. Chemotherapy
5.4.1. Market estimates and forecast, by region, 2013 – 2024

5.5. Enteral nutrition
5.5.1. Market estimates and forecast, by region, 2013 – 2024

5.6. Parenteral nutrition
5.6.1. Market estimates and forecast, by region, 2013 – 2024

5.7. Specialty pharmaceuticals
5.7.1. Market estimates and forecast, by region, 2013 – 2024

Browse Full Report@ https://www.gminsights.com/industry-analysis/us-home-infusion-therapy-market

Data Tables

TABLE 1. U.S. home infusion therapy industry 3600 synopsis, 2013 – 2024
TABLE 2. U.S. home infusion therapy market size, 2013-2024 (USD Million)
TABLE 3. U.S. home infusion therapy market size, by product, 2013-2024 (USD Million)
TABLE 4. U.S. home infusion therapy market size, by application, 2013-2024 (USD Million)
TABLE 5. U.S. home infusion therapy market size, by state, 2013-2024 (USD Million)
TABLE 6. Industry impact forces
TABLE 7. Infusion pumps estimates and forecast, by state, 2013 – 2024 (USD Million)
TABLE 8. Intravenous sets market size, by state, 2013 – 2024 (USD Million)
TABLE 9. IV cannulas market size, by state, 2013 – 2024 (USD Million)
TABLE 10. Needleless connectors market size, by state, 2013 – 2024 (USD Million)